Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 1 / 6 Announcement Summary Entity name ACTINOGEN MEDICAL LIMITED Announcement Type New announcement Date of this announcement Monday August 10, 2026 The +securities to be quoted...
Application for quotation of securities - ACW
Filed with ASX ·
6ix hasn’t read this filing yet.
Actinogen Medical Limited on 6ix
Earlier from Actinogen Medical
- Notification of cessation of securities - ACW
- ACW Bioshares presentation, strong cortisol rationale
- ACW webinar on the future of Alzheimers treatment
- June 2026 Quarterly activity report & Appendix 4C
- Xanamem depression trial published in British J Psychiatry
Later from Actinogen Medical
- Updated Securities Trading Policy
- ACW webinar today, The future of Alzheimers treatment
- Appendix 3Y-Malcolm McComas
- Appendix 3Y - Dr George Morstyn
- Corporate Governance Statement
Follow Actinogen Medical into a list and get an email when it puts out news.
Follow Actinogen Medical